Product Code: GDHC-TR-S008
Nanomedicine refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the ability to target specific cells or tissues. These materials are produced on a nanoscale level and are safe to introduce into the body. Applications for nanotechnology in medicine include imaging, diagnosis, or the delivery of drugs that will help medical professionals treat various diseases. In addition to targeted delivery of therapeutics, nanotechnology can also be used to release drugs in a controlled manner. This can result in improved outcomes for patients due to a reduction in toxicity, more efficient delivery of therapeutic molecules, and longer lifetime of drugs within the body.
- Players in the nanomedicine market range from private companies that make small annual revenues to large companies that dominate multiple industries, generating large revenues from many patents and FDA-approved drugs.
- Nanomedicines are a combination of nanotechnology with the drug itself, and are required to pass standard regulatory milestones. This includes proven safety and efficacy based on pre-clinical and clinical trials.
- Nanotechnologies are used as imagine contrast agents (microbubbles), for diagnostic purposes (liposomes and nanoparticles) and therapy (liposomes, nanoparticles and therapeutic microbubbles in development).
- This thematic report provides an overview of the use of nanotechnology in the medical device field.
- The key trends within this theme include understanding different patient populations and target specification.
- Our unique thematic analysis dives deep into the major sub-segments of nanotechnology in medicine, including liposomes, microbubbles and nanoparticles, and the market outlook for each type of technology.
- Companies that dominate the nanotechnology in medicine theme include Janssen, Gilead, GE Healthcare and Sanofi.
Reasons to buy
- Understand the nanotechnology industry through accessing the impacts and observing case studies identifying the key leaders, those who are likely to disrupt and those who fell behind.
- Assess the different types of nanoparticles, their current use in medicine and their future outlook.
- GlobalData's thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. It has a proven track record of identifying the important themes early, enabling companies to make the right investments ahead of the competition, and secure that all-important competitive advantage.
Table of Contents
- Technology/Scientific Trends
- Macroeconomic Trends
- Regulatory Trends
- INDUSTRY ANALYSIS
- Market Segmentation
- Generation of Revenue
- Competitive Analysis
- Case Studies
- Mergers and Acquisitions
- Clinical Trials
- VALUE CHAIN
- Public Companies
- Private Companies
- APPENDIX: OUR THEMATIC RESEARCH METHODOLOGY